Among PSMA-attractive features are prostate specificity for luminal secretory cells with minimal expression in other tissues and increasing levels from low grade to metastatic castrate-resistant prostate cancer (CRPC) [9, 10]. This evidence concerns the gene FOLH1 and Familial prostate cancer.